April 28, 2020 AACR 2020 – Gracell validates a novel Car-T target The Chinese group sees responses in all five subjects treated with its allogeneic anti-CD7 Car-T therapy.
April 22, 2020 AACR 2020 preview – no Tigit, but plenty of novel mechanisms Next week’s virtual meeting could resuscitate Ox40 agonists, but an important omission will disappoint.
